Beyond the overall minimisation of immunosuppression, which includes tapering steroids and eventually withdrawing them,225 early introduction of an mTOR inhibitor in conjunction with a calcineurin inhibitor taper or switching entirely to an mTOR inhibitor have been recommended to reduce the risk of tumour recurrence.128. Here, MTOR is linked to neoplasm.